# Cluster4-4 Analysis

## Proteins: 

ASPH, ATP2A1, BCAP31, CALR, CALU, CANX, CHM, CLGN, CLPTM1, CLPTM1L, CSGALNACT2, CYFIP2, CYP51A1, DDRGK1, DGAT1, DNAJB11, ELOVL5, ESYT1, FAM234B, FDFT1, FKBP8, GCG, GDAP2, GNPTG, HM13, HSP90B1, IKBIP, KCTD20, KTN1, LRPAP1, LRRC59, MOGS, MXRA7, NSDHL, P4HB, PDIA6, PTPN1, QPCT, RCN1, SCARF2, SELENOS, SGPL1, SLC39A7, SMAP2, SOAT1, STC2, TMX1, VAPA, VAPB, VIP, ZSCAN21

Title: Endoplasmic Reticulum Protein Interaction System

Summary: The Endoplasmic Reticulum Protein Interaction System is a complex of human proteins that are predominantly localized in the endoplasmic reticulum (ER) and involved in various cellular processes such as protein folding, calcium ion binding, and response to ER stress. The system includes 44 proteins with protein binding activity, 33 proteins localized in the ER, and 30 proteins associated with the ER membrane. The proteins in this system are involved in diverse biological processes, including protein folding, ER stress response, and calcium ion homeostasis. Notably, several proteins are involved in the ubiquitin-dependent ERAD pathway and protein folding in the ER. The system's name reflects its primary cellular location and function in the endoplasmic reticulum.

References:

1. [HSP90B1, CANX, and CALR in the endoplasmic reticulum chaperone complex](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1237095/)
2. [Protein folding and quality control in the endoplasmic reticulum](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034884/)
3. [Endoplasmic reticulum stress and the unfolded protein response](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694720/)
4. [Calcium signaling and the secretory activity of the endoplasmic reticulum](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844702/)
5. [The ubiquitin-proteasome system and endoplasmic reticulum-associated degradation](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2807639/)

## Gene Feature Summary: 

| Feature | Number of Genes | Genes |
| --- | --- | --- |
| protein binding | 44 | HSP90B1, GNPTG, CANX, LRPAP1, ELOVL5, CLPTM1, SELENOS, CLPTM1L, PTPN1, DDRGK1, DGAT1, TMX1, HM13, SCARF2, SGPL1, CSGALNACT2, FDFT1, QPCT, ASPH, ATP2A1, BCAP31, CALR, CALU, CHM, CYFIP2, DNAJB11, ESYT1, FKBP8, GCG, GDAP2, IKBIP, KTN1, LRRC59, NSDHL, P4HB, PDIA6, RCN1, SLC39A7, SMAP2, SOAT1, VAPA, VAPB, VIP, ZSCAN21 |
| endoplasmic reticulum | 33 | HSP90B1, CANX, LRPAP1, MXRA7, ELOVL5, CYP51A1, SELENOS, CLGN, PTPN1, DDRGK1, HM13, SGPL1, FDFT1, ASPH, BCAP31, CALR, CALU, DNAJB11, ESYT1, FKBP8, IKBIP, KTN1, LRRC59, MOGS, NSDHL, P4HB, PDIA6, RCN1, SLC39A7, SOAT1, STC2, VAPA, VAPB |
| endoplasmic reticulum membrane | 30 | HSP90B1, CANX, ELOVL5, CYP51A1, SELENOS, CLGN, CLPTM1L, DDRGK1, DGAT1, TMX1, HM13, SGPL1, FDFT1, ASPH, ATP2A1, BCAP31, CALR, CALU, ESYT1, FKBP8, IKBIP, KTN1, LRRC59, MOGS, NSDHL, PDIA6, SLC39A7, SOAT1, VAPA, VAPB |
| membrane | 27 | HSP90B1, CANX, MXRA7, ELOVL5, CLPTM1, CYP51A1, CLPTM1L, FAM234B, DGAT1, HM13, SCARF2, CSGALNACT2, FDFT1, ATP2A1, BCAP31, CALR, CALU, CYFIP2, DNAJB11, ESYT1, FKBP8, IKBIP, KTN1, LRRC59, MOGS, SLC39A7, SOAT1 |
| plasma membrane | 14 | LRPAP1, CLPTM1, SELENOS, PTPN1, DGAT1, HM13, ASPH, BCAP31, ESYT1, GCG, KTN1, PDIA6, VAPA, VAPB |
| endoplasmic reticulum lumen | 11 | HSP90B1, CANX, CALR, CALU, DNAJB11, GCG, KTN1, P4HB, PDIA6, RCN1, STC2 |
| cytosol | 11 | HSP90B1, PTPN1, BCAP31, CALR, CHM, CYFIP2, FKBP8, P4HB, PDIA6, SMAP2, VAPA |
| calcium ion binding | 9 | HSP90B1, CANX, CLGN, ASPH, ATP2A1, CALR, CALU, ESYT1, RCN1 |
| protein folding | 9 | HSP90B1, CANX, CLGN, CALR, DNAJB11, FKBP8, MOGS, P4HB, PDIA6 |
| extracellular exosome | 9 | HSP90B1, GNPTG, CANX, QPCT, CALR, CYFIP2, MOGS, P4HB, PDIA6 |
| cytoplasm | 9 | PTPN1, DDRGK1, CALR, CHM, CYFIP2, KCTD20, LRRC59, SMAP2, VAPB |
| extracellular region | 8 | HSP90B1, LRPAP1, QPCT, CALR, CALU, GCG, P4HB, VIP |
| Golgi apparatus | 8 | GNPTG, LRPAP1, FAM234B, CALR, CALU, SLC39A7, STC2, VAPB |
| RNA binding | 7 | HSP90B1, CANX, PTPN1, CALR, KTN1, LRRC59, P4HB |
| response to endoplasmic reticulum stress | 7 | HSP90B1, DDRGK1, TMX1, ATP2A1, BCAP31, P4HB, PDIA6 |
| nucleus | 6 | HSP90B1, CALR, CHM, CYFIP2, DNAJB11, ZSCAN21 |
| unfolded protein binding | 5 | HSP90B1, CANX, CLGN, CALR, DNAJB11 |
| ubiquitin-dependent ERAD pathway | 5 | HSP90B1, CANX, SELENOS, CLGN, CALR |
| protein folding in endoplasmic reticulum | 5 | HSP90B1, CANX, CALR, P4HB, VAPA |
| negative regulation of apoptotic process | 5 | HSP90B1, DDRGK1, FKBP8, GCG, VIP |
| protein-containing complex | 5 | HSP90B1, CANX, PTPN1, FKBP8, P4HB |
| melanosome | 5 | HSP90B1, CANX, CALU, P4HB, PDIA6 |
| perinuclear region of cytoplasm | 5 | HSP90B1, CALR, CYFIP2, STC2, VAPA |
| protein homodimerization activity | 5 | GNPTG, HM13, ATP2A1, STC2, VAPB |
| endomembrane system | 5 | LRPAP1, CLPTM1, CLPTM1L, TMX1, FKBP8 |
| enzyme binding | 5 | SELENOS, PTPN1, P4HB, STC2, VAPB |
| cadherin binding | 5 | PTPN1, KTN1, LRRC59, VAPA, VAPB |
| metal ion binding | 5 | CSGALNACT2, FDFT1, FKBP8, SMAP2, ZSCAN21 |
| extracellular space | 5 | CALR, DNAJB11, GCG, PDIA6, STC2 |
| focal adhesion | 4 | HSP90B1, SCARF2, CALR, P4HB |
| endoplasmic reticulum chaperone complex | 4 | HSP90B1, DNAJB11, P4HB, PDIA6 |
| Golgi membrane | 4 | GNPTG, CSGALNACT2, BCAP31, VAPA |
| lumenal side of endoplasmic reticulum membrane | 4 | CANX, HM13, BCAP31, CALR |
| endoplasmic reticulum unfolded protein response | 4 | SELENOS, PTPN1, STC2, VAPB |
| apoptotic process | 4 | CLPTM1L, BCAP31, CYFIP2, FKBP8 |
| identical protein binding | 4 | DGAT1, ESYT1, FKBP8, GCG |
| spermatogenesis | 4 | SGPL1, BCAP31, CALR, ZSCAN21 |
| intracellular calcium ion homeostasis | 4 | ATP2A1, CALR, STC2, VAPB |
| endoplasmic reticulum to Golgi vesicle-mediated transport | 4 | BCAP31, P4HB, VAPA, VAPB |
| sarcoplasmic reticulum lumen | 3 | HSP90B1, CALR, CALU |
| collagen-containing extracellular matrix | 3 | HSP90B1, MXRA7, CALR |
| signaling receptor binding | 3 | LRPAP1, DNAJB11, GCG |
| endoplasmic reticulum-Golgi intermediate compartment | 3 | LRPAP1, P4HB, PDIA6 |
| cell surface | 3 | LRPAP1, HM13, CALR |
| external side of plasma membrane | 3 | CLPTM1, CALR, P4HB |
| cholesterol biosynthetic process | 3 | CYP51A1, FDFT1, NSDHL |
| protein folding chaperone | 3 | CLGN, CALR, FKBP8 |
| zinc ion binding | 3 | PTPN1, QPCT, CALR |
|  cell population proliferation | 3 | DDRGK1, CALR, VIP |
|  gene expression | 3 | DDRGK1, CALR, FKBP8 |
| mitochondrion | 3 | ATP2A1, BCAP31, FKBP8 |
| hormone activity | 3 | GCG, STC2, VIP |
| protein heterodimerization activity | 3 | P4HB, VAPA, VAPB |
| ATP binding | 2 | HSP90B1, ATP2A1 |
| ATP hydrolysis activity | 2 | HSP90B1, ATP2A1 |
| low-density lipoprotein particle receptor binding | 2 | HSP90B1, LRPAP1 |
| protein transport | 2 | HSP90B1, KTN1 |
| retrograde protein transport, ER to cytosol | 2 | HSP90B1, SELENOS |
| sequestering of calcium ion | 2 | HSP90B1, CALR |
| endocytic vesicle lumen | 2 | HSP90B1, CALR |
| carbohydrate binding | 2 | CANX, CALR |
| viral protein processing | 2 | CANX, MOGS |
| smooth endoplasmic reticulum | 2 | CANX, CALR |
| rough endoplasmic reticulum | 2 | CANX, HM13 |
| nuclear membrane | 2 | CANX, VAPA |
| neuronal cell body | 2 | CANX, ELOVL5 |
| mitochondria-associated endoplasmic reticulum membrane | 2 | CANX, BCAP31 |
| endoplasmic reticulum quality control compartment | 2 | CANX, CALR |
| negative regulation of amyloid-beta clearance | 2 | LRPAP1, CYP51A1 |
| endosome lumen | 2 | LRPAP1, PTPN1 |
| sphingolipid biosynthetic process | 2 | ELOVL5, SGPL1 |
| cell differentiation | 2 | CLPTM1, ZSCAN21 |
| iron ion binding | 2 | CYP51A1, CALR |
| heme binding | 2 | CYP51A1, STC2 |
| steroid biosynthetic process | 2 | CYP51A1, FDFT1 |
|  gluconeogenesis | 2 | SELENOS, GCG |
| negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway | 2 | SELENOS, PTPN1 |
| Derlin-1 retrotranslocation complex | 2 | SELENOS, HM13 |
| IRE1-mediated unfolded protein response | 2 | PTPN1, VAPB |
| cytoplasmic side of endoplasmic reticulum membrane | 2 | PTPN1, HM13 |
| cytoskeleton | 2 | FAM234B, P4HB |
| negative regulation of gene expression | 2 | DDRGK1, STC2 |
|  protein stability | 2 | DDRGK1, ASPH |
|  transcription by RNA polymerase II | 2 | DDRGK1, ZSCAN21 |
| protein localization to endoplasmic reticulum | 2 | DDRGK1, VAPA |
| very-low-density lipoprotein particle assembly | 2 | DGAT1, SOAT1 |
| ubiquitin protein ligase binding | 2 | HM13, CALR |
| in utero embryonic development | 2 | HM13, RCN1 |
| roof of mouth development | 2 | SGPL1, ASPH |
| face morphogenesis | 2 | SGPL1, ASPH |
| Golgi cisterna membrane | 2 | CSGALNACT2, BCAP31 |
|  proteolysis | 2 | ASPH, CYFIP2 |
| activation of cysteine-type endopeptidase activity | 2 | ASPH, CYFIP2 |
| sarcoplasmic reticulum membrane | 2 | ASPH, ATP2A1 |
| negative regulation of endoplasmic reticulum calcium ion concentration | 2 | ATP2A1, BCAP31 |
|  mitochondrial calcium ion concentration | 2 | ATP2A1, BCAP31 |
| lipid droplet | 2 | BCAP31, NSDHL |
| endoplasmic reticulum-Golgi intermediate compartment membrane | 2 | BCAP31, CALR |
| integrin binding | 2 | CALR, P4HB |
|  DNA-templated transcription | 2 | CALR, ZSCAN21 |
|  substrate adhesion-dependent cell spreading | 2 | CALR, P4HB |
| nuclear envelope | 2 | CALR, LRRC59 |
| GTPase activator activity | 2 | CHM, SMAP2 |
| small GTPase binding | 2 | CHM, CYFIP2 |
| neuron projection | 2 | CYFIP2, VIP |
| phospholipid transport | 2 | ESYT1, VAPA |
| endoplasmic reticulum-plasma membrane tethering | 2 | ESYT1, VAPB |
| smoothened signaling pathway | 2 | FKBP8, NSDHL |
| camera-type eye development | 2 | FKBP8, RCN1 |
| G protein-coupled receptor signaling pathway | 2 | GCG, VIP |
| adenylate cyclase-activating G protein-coupled receptor signaling pathway | 2 | GCG, VIP |
| cholesterol metabolic process | 2 | NSDHL, SOAT1 |
| protein disulfide isomerase activity | 2 | P4HB, PDIA6 |
| protein-disulfide reductase activity | 2 | P4HB, PDIA6 |
| cellular response to hypoxia | 2 | P4HB, STC2 |
| nucleoplasm | 2 | SLC39A7, SMAP2 |
| microtubule binding | 2 | VAPA, VAPB |
| FFAT motif binding | 2 | VAPA, VAPB |
| endoplasmic reticulum organization | 2 | VAPA, VAPB |
| COPII-coated vesicle budding | 2 | VAPA, VAPB |
| endoplasmic reticulum exit site | 2 | VAPA, VAPB |

